What is nOCD?
nOCD is a digital health platform dedicated to helping individuals overcome Obsessive-Compulsive Disorder (OCD). The company offers live video sessions with licensed therapists who specialize in Exposure and Response Prevention (ERP), a clinically proven and gold-standard treatment for OCD. By providing accessible and expert-led therapy, nOCD aims to empower individuals to regain control of their lives and manage their condition effectively. Their approach emphasizes the critical role of specialized therapeutic interventions in addressing the complexities of OCD.
How much funding has nOCD raised?
nOCD has raised a total of $80.2M across 5 funding rounds:
Private Equity
$1M
Debt
$150K
Series A
$12M
Series B
$33M
Other Financing Round
$34M
Private Equity (2017): $1M with participation from 7 Wire Ventures
Debt (2020): $150K led by PPP
Series A (2020): $12M supported by 7Wire Ventures, Chicago Ventures, Hyde Park Angels, and Meridian Street Capital
Series B (2021): $33M featuring Kaiser Permanente Ventures, Eight Roads Ventures, F-Prime Capital, 7wireVentures, Health Enterprise Partners, and Chicago Ventures
Other Financing Round (2023): $34M backed by Cigna Ventures, Kaiser Permanente Ventures, Longitude Capital, Eight Roads Capital, 7wireVentures, and Health Enterprise Partners
Key Investors in nOCD
Cigna Ventures
Cigna Ventures is a venture capital arm focused on investments that align with Cigna's mission to improve customer health and security, indicating a strategic interest in innovative healthcare solutions.
7wireVentures
7wireVentures is a firm that invests in early-stage digital health companies, aiming to empower consumers and revolutionize healthcare through innovative solutions and personalized coaching.
Health Enterprise Partners
Health Enterprise Partners is a venture capital firm that partners with organizations transforming healthcare delivery, leveraging deep industry knowledge and a network of strategic payer and provider partners.
What's next for nOCD?
With the recent influx of major strategic investment, nOCD is poised for accelerated growth and enhanced service delivery. The company is likely to leverage this capital to expand its network of specialized therapists, further develop its technology platform, and increase its market reach. Strategic partnerships, potentially with entities like Cigna Ventures and Kaiser Permanente Ventures, could also play a crucial role in integrating nOCD's services into broader healthcare ecosystems, thereby increasing accessibility and impact for individuals suffering from OCD.
See full nOCD company page
